Health ❯ Healthcare ❯ Medical Research ❯ Oncology

Breast Cancer

GLP-1 Drugs Linked to Lower Death and Recurrence in Breast Cancer, Large Study Finds

Researchers urge randomized trials before using these drugs to guide breast cancer care.

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

Phase II Trial Finds 24 Gy Preoperative Radiation With Pembrolizumab Boosts T‑Cell Infiltration in HR+/HER2− Breast Cancer

Preoperative MRI Fails to Improve Outcomes in Early HR-Negative Breast Cancer

Tucatinib Added to First-Line HER2 Maintenance Prolongs Progression-Free Survival in Phase 3 Trial

AI Multimodal Model Outperforms Oncotype DX for Long-Term Breast Cancer Recurrence Risk

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

Roche’s Giredestrant Plus Everolimus Extends PFS in Phase 3 evERA for ER-Positive, HER2-Negative Breast Cancer

Phase 3 Trial Finds Tukysa Improves PFS in First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

NF1-Low ER+ Breast Cancers Identified as Likely Responders to CDK4/6 Inhibitors

Celcuity’s Gedatolisib Combos Yield Up to 76% Progression-Free Survival Gain in Phase 3 Trial

Low-Dose Vitamin D Supplementation Enhances Chemotherapy Success in Breast Cancer Trial